NL-OMON35831已完成3 期
Safety and Effectiveness using DEXmedetomidine sedation versus Propofol/Alfentanil sedation during oesophagus interventions. (SEDEX) - Safety and Effectiveness during DEXmedetomidine sedation.
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age range * 18 years
- •ASA classification I * III
- •Patients, undergoing elective oesophagus intervention
- •Written informed consent
排除标准
- •Age range < 18 years
- •ASA classification IV and V
- •Allergic reaction to planned medication in the patients* medical history
- •Unregulated hypertension
- •Hypovolemia or hypotension (SBP <80 or MAP <50)
- •Sever bradycardia (rate < 50) and / or related bradydysrhymias (e.g. advanced heart block)
- •Impaired ventricular functions (EF <30%)
- •GFR less than 15ml/min or undergoing hemodialysis
- •End stage liver disease
- •Substance abuse
研究者
相似试验
已完成
不适用
Patient safety and satisfaction with dexmedetomidine sedation during endoscopic oesophageal interventionsISRCTN68599804Academic Medical Centre (AMC) (Netherlands)64
已完成
4 期
A clinical study to find whether dexmedetomidine provides adequate comfort to patients during awake nasal fibreoptic intubatioCTRI/2012/09/002948Kasturba Hospital KMC Manipal36
尚未招募
Unknown
Efficacy and Safety of use of Dexmedetomidine for Hypotensive Anaesthesia in Patients undergoing Functional Endoscopic sinus surgeryCTRI/2024/07/070582Dr Sridevi Mulimani
已完成
不适用
To analyse whether Dexmedetomidine(Central Alpha 2 Agonist) can be used safely as a sedative/analgesic agent In patients undergoing Laparoscopic Tubal Ligation And with/without MTPCTRI/2017/11/010353ALL INDIA INSTITUTE OF MEDICAL SCIENCES80
进行中（未招募）
不适用
The effect and safety of dexmedetomidine as an additive to ropivacaine for interscalene brachial plexus blocks (regional anesthesia) for shoulder surgeryThe goal of the present study is to investigate the safety and efficiacy of dexmedetomidine added toropivacaine for interscalene brachial plexus nerve block for shoulder surgery in humans.Provided the initial safety can be established, the trial will continue to evaluate secondary goalsincluding the duration of analgesia, onset of sensory and motor blockade, and opioid-inducedside effects. Tertiary outcomes will include activity, sleep, and subject satisfaction.EUCTR2011-002175-42-ATParacelsus Medizinische Universität - Universitätsklinik für Anästhesie